Search tips
Search criteria 


Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 1988 June; 51(6): 745–752.
PMCID: PMC1033142

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.


The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • WOODARD JS. Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases. J Neuropathol Exp Neurol. 1962 Jul;21:442–449. [PubMed]
  • Whitehouse PJ, Hedreen JC, White CL, 3rd, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983 Mar;13(3):243–248. [PubMed]
  • Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease? Clin Neuropathol. 1984 Sep-Oct;3(5):185–192. [PubMed]
  • Yokochi M, Narabayashi H, Iizuka R, Nagatsu T. Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects. Adv Neurol. 1984;40:407–413. [PubMed]
  • Sachdev HS, Forno LS, Kane CA. Joseph disease: a multisystem degenerative disorder of the nervous system. Neurology. 1982 Feb;32(2):192–195. [PubMed]
  • Dooling EC, Schoene WC, Richardson EP., Jr Hallervorden-Spatz syndrome. Arch Neurol. 1974 Jan;30(1):70–83. [PubMed]
  • Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol. 1967 Mar;16(3):232–243. [PubMed]
  • BETHLEM J, DEN HARTOG JAGER WA. The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). J Neurol Neurosurg Psychiatry. 1960 Feb;23:74–80. [PMC free article] [PubMed]
  • Hunter S. The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol. 1985;68(1):53–58. [PubMed]
  • Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology. 1984 Oct;87(4):848–856. [PubMed]
  • Goldman JE, Yen SH, Chiu FC, Peress NS. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science. 1983 Sep 9;221(4615):1082–1084. [PubMed]
  • Dickson DW, Kress Y, Crowe A, Yen SH. Monoclonal antibodies to Alzheimer neurofibrillary tangles. 2. Demonstration of a common antigenic determinant between ANT and neurofibrillary degeneration in progressive supranuclear palsy. Am J Pathol. 1985 Aug;120(2):292–303. [PubMed]
  • Nakazato Y, Sasaki A, Hirato J, Ishida Y. Immunohistochemical localization of neurofilament protein in neuronal degenerations. Acta Neuropathol. 1984;64(1):30–36. [PubMed]
  • Kahn J, Anderton BH, Gibb WR, Lees AJ, Wells FR, Marsden CD. Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases. N Engl J Med. 1985 Aug 22;313(8):520–521. [PubMed]
  • Kosaka K. Lewy bodies in cerebral cortex, report of three cases. Acta Neuropathol. 1978 May 24;42(2):127–134. [PubMed]
  • Wisniewski HM, Shek JW, Gruca S, Sturman JA. Aluminum-induced neurofibrillary changes in axons and dendrites. Acta Neuropathol. 1984;63(3):190–197. [PubMed]
  • Burns RS, Markey SP, Phillips JM, Chiueh CC. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Can J Neurol Sci. 1984 Feb;11(1 Suppl):166–168. [PubMed]
  • Forno LS, Langston JW, DeLanney LE, Irwin I, Ricaurte GA. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol. 1986 Oct;20(4):449–455. [PubMed]
  • Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. [PubMed]
  • BEHEIM-SCHWARZBACH D. Uber Zelleib-Veränderungen im Nucleus coeruleus bei Parkinson-Symptomen. J Nerv Ment Dis. 1952 Dec;116(6):619–632. [PubMed]
  • Tomonaga M. Neuropathology of the locus ceruleus: a semi-quantitative study. J Neurol. 1983;230(4):231–240. [PubMed]
  • Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson's disease in a Scottish city. Br Med J (Clin Res Ed) 1986 Feb 22;292(6519):534–536. [PMC free article] [PubMed]
  • Rajput AH, Rozdilsky B, Hornykiewicz O, Shannak K, Lee T, Seeman P. Reversible drug-induced parkinsonism. Clinicopathologic study of two cases. Arch Neurol. 1982 Oct;39(10):644–646. [PubMed]
  • Koller W, O'Hara R, Weiner W, Lang A, Nutt J, Agid Y, Bonnet AM, Jankovic J. Relationship of aging to Parkinson's disease. Adv Neurol. 1987;45:317–321. [PubMed]
  • Calne DB, Langston JW. Aetiology of Parkinson's disease. Lancet. 1983 Dec 24;2(8365-66):1457–1459. [PubMed]
  • Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. [PubMed]
  • Agid Y, Blin J. Nerve cell death in degenerative diseases of the central nervous system: clinical aspects. Ciba Found Symp. 1987;126:3–29. [PubMed]
  • Golbe LI, Cody RA, Duvoisin RC. Smoking and Parkinson's disease. Search for a dose-response relationship. Arch Neurol. 1986 Aug;43(8):774–778. [PubMed]
  • Eldridge R, Ince SE. The low concordance rate for Parkinson's disease in twins: a possible explanation. Neurology. 1984 Oct;34(10):1354–1356. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group